Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney | 6 | 2015 | 521 | 1.140 |
Why?
|
| Receptors, Angiotensin | 4 | 2011 | 61 | 1.070 |
Why?
|
| Angiotensin I | 4 | 2021 | 237 | 1.050 |
Why?
|
| Angiotensin II | 4 | 2021 | 241 | 1.030 |
Why?
|
| Peptide Fragments | 4 | 2021 | 415 | 0.980 |
Why?
|
| Spermatozoa | 5 | 2006 | 29 | 0.780 |
Why?
|
| Cell Nucleus | 3 | 2011 | 111 | 0.710 |
Why?
|
| Nitric Oxide | 3 | 2011 | 121 | 0.670 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 150 | 0.650 |
Why?
|
| Renin-Angiotensin System | 5 | 2021 | 173 | 0.500 |
Why?
|
| Kidney Cortex | 3 | 2015 | 25 | 0.500 |
Why?
|
| Fallopian Tubes | 3 | 2006 | 6 | 0.490 |
Why?
|
| Sheep | 7 | 2015 | 194 | 0.450 |
Why?
|
| Seminal Vesicle Secretory Proteins | 2 | 2006 | 2 | 0.440 |
Why?
|
| Reactive Oxygen Species | 3 | 2011 | 163 | 0.440 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2010 | 129 | 0.360 |
Why?
|
| Fetal Development | 1 | 2011 | 26 | 0.330 |
Why?
|
| Betamethasone | 1 | 2011 | 53 | 0.320 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 90 | 0.310 |
Why?
|
| Kidney Tubules, Proximal | 3 | 2016 | 39 | 0.310 |
Why?
|
| Animals | 14 | 2016 | 8199 | 0.310 |
Why?
|
| Glucocorticoids | 1 | 2011 | 146 | 0.300 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2009 | 22 | 0.290 |
Why?
|
| Signal Transduction | 1 | 2011 | 727 | 0.270 |
Why?
|
| Sperm Motility | 3 | 2006 | 8 | 0.250 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 478 | 0.250 |
Why?
|
| Semen | 2 | 2003 | 10 | 0.240 |
Why?
|
| Angiotensinogen | 2 | 2016 | 59 | 0.240 |
Why?
|
| Mitochondria | 2 | 2016 | 211 | 0.210 |
Why?
|
| Epididymis | 1 | 2003 | 8 | 0.200 |
Why?
|
| Peptide Hydrolases | 2 | 2015 | 17 | 0.190 |
Why?
|
| Enzyme Inhibitors | 3 | 2010 | 174 | 0.180 |
Why?
|
| Losartan | 3 | 2011 | 64 | 0.180 |
Why?
|
| Macaca fascicularis | 2 | 2000 | 542 | 0.170 |
Why?
|
| Chromatography, Agarose | 1 | 2021 | 5 | 0.170 |
Why?
|
| Radioimmunoassay | 1 | 2021 | 25 | 0.170 |
Why?
|
| Reference Standards | 1 | 2021 | 28 | 0.170 |
Why?
|
| Specimen Handling | 1 | 2021 | 30 | 0.170 |
Why?
|
| Female | 11 | 2016 | 19947 | 0.160 |
Why?
|
| Progesterone | 1 | 2000 | 78 | 0.160 |
Why?
|
| Blood Pressure | 2 | 2016 | 861 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2010 | 299 | 0.150 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 556 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1999 | 17 | 0.150 |
Why?
|
| Male | 12 | 2016 | 19443 | 0.150 |
Why?
|
| Calcium | 1 | 2000 | 339 | 0.140 |
Why?
|
| Cattle | 3 | 2006 | 116 | 0.120 |
Why?
|
| Wrist Injuries | 1 | 2015 | 41 | 0.110 |
Why?
|
| Renin | 1 | 2015 | 107 | 0.110 |
Why?
|
| Social Support | 1 | 2016 | 180 | 0.110 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2015 | 56 | 0.110 |
Why?
|
| Radius Fractures | 1 | 2015 | 68 | 0.110 |
Why?
|
| Fracture Fixation, Internal | 1 | 2015 | 125 | 0.100 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2011 | 66 | 0.100 |
Why?
|
| Mothers | 1 | 2014 | 74 | 0.100 |
Why?
|
| Pre-Eclampsia | 1 | 2014 | 62 | 0.100 |
Why?
|
| Depression | 1 | 2016 | 420 | 0.100 |
Why?
|
| Premature Birth | 1 | 2014 | 73 | 0.100 |
Why?
|
| Humans | 7 | 2021 | 32284 | 0.090 |
Why?
|
| Water-Electrolyte Balance | 1 | 2011 | 17 | 0.090 |
Why?
|
| Hispanic Americans | 1 | 2016 | 772 | 0.090 |
Why?
|
| Pregnancy | 2 | 2014 | 961 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2015 | 132 | 0.080 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2010 | 18 | 0.080 |
Why?
|
| Radioligand Assay | 1 | 2010 | 24 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2010 | 34 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 95 | 0.080 |
Why?
|
| Rats | 2 | 2011 | 1895 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 83 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 89 | 0.080 |
Why?
|
| Leucine | 1 | 2009 | 23 | 0.080 |
Why?
|
| African Americans | 1 | 2016 | 1335 | 0.080 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 133 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 471 | 0.080 |
Why?
|
| Pyridines | 1 | 2009 | 79 | 0.080 |
Why?
|
| Imidazoles | 1 | 2009 | 97 | 0.070 |
Why?
|
| Autoradiography | 1 | 2009 | 51 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2009 | 54 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 1 | 2009 | 41 | 0.070 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2009 | 63 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 545 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 1158 | 0.070 |
Why?
|
| Fetus | 1 | 2009 | 76 | 0.070 |
Why?
|
| Protein Binding | 1 | 2009 | 244 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 290 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 359 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 1083 | 0.070 |
Why?
|
| Structural Homology, Protein | 1 | 2006 | 1 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 74 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2006 | 110 | 0.060 |
Why?
|
| Epithelium | 2 | 2003 | 22 | 0.060 |
Why?
|
| Binding Sites | 1 | 2006 | 144 | 0.060 |
Why?
|
| Heparin | 1 | 2006 | 65 | 0.060 |
Why?
|
| Mice | 1 | 2011 | 2571 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2006 | 204 | 0.060 |
Why?
|
| Cell Line | 2 | 2016 | 454 | 0.050 |
Why?
|
| Hypertension | 1 | 2011 | 979 | 0.050 |
Why?
|
| Time Factors | 1 | 2009 | 2205 | 0.050 |
Why?
|
| Seminal Vesicles | 1 | 2003 | 3 | 0.050 |
Why?
|
| Seminal Plasma Proteins | 1 | 2003 | 2 | 0.050 |
Why?
|
| Sperm Capacitation | 2 | 2001 | 3 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2003 | 109 | 0.050 |
Why?
|
| Lectins | 1 | 2001 | 11 | 0.040 |
Why?
|
| Sperm Tail | 1 | 2000 | 1 | 0.040 |
Why?
|
| Tyrosine | 1 | 2000 | 24 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2000 | 250 | 0.040 |
Why?
|
| Bucladesine | 1 | 1999 | 6 | 0.040 |
Why?
|
| Genistein | 1 | 1999 | 17 | 0.040 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1999 | 17 | 0.040 |
Why?
|
| Proteins | 1 | 2000 | 149 | 0.040 |
Why?
|
| Caffeine | 1 | 1999 | 28 | 0.040 |
Why?
|
| Sheep, Domestic | 1 | 2016 | 17 | 0.030 |
Why?
|
| Biological Transport | 1 | 2016 | 75 | 0.030 |
Why?
|
| New York City | 1 | 2016 | 12 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 80 | 0.030 |
Why?
|
| Mitochondrial Membranes | 1 | 2016 | 27 | 0.030 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2016 | 30 | 0.030 |
Why?
|
| Social Perception | 1 | 2016 | 22 | 0.030 |
Why?
|
| Social Class | 1 | 2016 | 90 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 128 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2015 | 110 | 0.030 |
Why?
|
| Insulysin | 1 | 2015 | 6 | 0.030 |
Why?
|
| Median Nerve | 1 | 2015 | 50 | 0.030 |
Why?
|
| Bone Plates | 1 | 2015 | 71 | 0.030 |
Why?
|
| Decompression, Surgical | 1 | 2015 | 55 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 363 | 0.030 |
Why?
|
| Aldosterone | 1 | 2014 | 26 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2015 | 239 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2014 | 43 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 555 | 0.030 |
Why?
|
| Adult | 2 | 2016 | 9259 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 854 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 10265 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 651 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 1840 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 11853 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 666 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 520 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2240 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 2316 | 0.020 |
Why?
|
| Maleimides | 1 | 2009 | 8 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 43 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2009 | 123 | 0.020 |
Why?
|
| Indoles | 1 | 2009 | 65 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 3934 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 3416 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 3519 | 0.020 |
Why?
|
| Fucose | 1 | 2001 | 2 | 0.010 |
Why?
|
| Acrosome | 1 | 2001 | 2 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2001 | 8 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2001 | 3 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 2001 | 15 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 2001 | 11 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 93 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2001 | 52 | 0.010 |
Why?
|
Gwathmey-Williams's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(45)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_